Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Genotype-Guided Warfarin Therapy Trial (WARFPGX)

This study has been completed.
UNC Institute for Pharmacogenomics and Individualized Therapy
Information provided by (Responsible Party):
University of North Carolina, Chapel Hill Identifier:
First received: April 6, 2009
Last updated: May 5, 2016
Last verified: October 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2012
  Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):